If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Massimo Guidoboni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 0 Similar Profiles
Melanoma Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences
Chlamydophila psittaci Medicine & Life Sciences
Marginal Zone B-Cell Lymphoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Lymphocytes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2018

  • 5420 Citations
  • 26 h-Index
  • 74 Article
  • 2 Comment/debate
  • 1 Chapter
  • 1 Letter
3 Citations (Scopus)

Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: Protocol for a phase II randomised trial (ACDC Adjuvant Trial)

Ridolfi, L., De Rosa, F., Fiammenghi, L., Petrini, M., Granato, A. M., Ancarani, V., Pancisi, E., Soldati, V., Cassan, S., Bulgarelli, J., Riccobon, A., Gentili, G., Nanni, O., Framarini, M., Tauceri, F. & Guidoboni, M., Aug 1 2018, In : BMJ Open. 8, 8, e021701.

Research output: Contribution to journalArticle

Dendritic Cells
Melanoma
Vaccination
Delayed Hypersensitivity
Vaccines
1 Citation (Scopus)
Conflict of Interest
Melanoma
Survival
Italy
Genes
3 Citations (Scopus)

CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab

Italian Melanoma Intergroup (IMI), Jul 1 2018, In : European Journal of Cancer. 97, p. 59-61 3 p.

Research output: Contribution to journalLetter

CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab

Queirolo, P., Dozin, B., Morabito, A., Banelli, B., Carosio, R., Fontana, V., Ferrucci, P. F., Martinoli, C., Cocorocchio, E., Ascierto, P. A., Madonna, G., Simeone, E., De Galitiis, F., Antonini Cappellini, G. C., Marchetti, P., Guida, M., Tommasi, S., Ghilardi, L., Merelli, B., Fava, P. & 7 others, Osella-Abate, S., Guidoboni, M., Romani, M., Ferone, D., Spagnolo, F., Pistillo, M. P. & (IMI), I. M. I., 2018, In : European journal of cancer. 97, p. 59-61 3 p.

Research output: Contribution to journalArticle

Dabrafenib-trametinib combination in 'field-practice': An Italian experience

Depenni, R., De Rosa, F., Greco, S., Ridolfi, L., Pellacani, G., Ponti, G., Cascinu, S. & Guidoboni, M., 2018, In : Future Oncology. 14, 20, p. 2045-2052 8 p.

Research output: Contribution to journalArticle